Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol

Introduction Standard treatment for nodular/bronchiectatic Mycobacterium avium complex lung disease (NB MAC-LD), excluding severe-status cases, differs between Japan and other countries. Internationally, three-drug combination intermittent treatment (three times a week administration) with macrolide...

Full description

Bibliographic Details

Published in:	BMJ Open Respiratory Research
Main Authors:	Akiko M Saito, Yoshikazu Inoue, Taku Nakagawa, Hiroya Hashimoto, Mitsuaki Yagi, Yoshihito Kogure, Masahiro Sekimizu, Kenji Ogawa
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2019-10-01
Online Access:	https://bmjopenrespres.bmj.com/content/6/1/e000434.full